FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma - Contacts and Locations

FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00066638. Last updated on November 16, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00066638

Locations


United States, New York
	Albert Einstein Cancer Center at Albert Einstein College of Medicine
	Bronx, New York, United States, 10461
	Mount Sinai Medical Center
	New York, New York, United States, 10029
	New York Weill Cornell Cancer Center at Cornell University
	New York, New York, United States, 10021

Sponsors and Collaborators

Albert Einstein College of Medicine of Yeshiva University

Investigators


Principal Investigator:	Ruben Niesvizky, MD	Weill Medical College of Cornell University